About: Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Sector: Healthcare
Industry: Medical Devices
Latest price: $2.38 (+5.31%)
STIM NASDAQ Neuronetics Inc
Neuronetics Inc share price
Atividade de preço de STIM
Último preço
$ 2,380
Variação (24h)
0,12 USD (5,31%)
Volume
828.65K
Volume (média 4 sem.)
-
Abertura
$ 2,27
Variação do dia
$ 2,24 - $ 2,48
Fechamento anterior
$ 2,26
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
STIM price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals